Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study-Reference-Cited by-同舟云学术

Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study

Published:2016-04-06 Issue:6 Volume:16 Page:803-807
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Tadrous Mina¹²³,Martins Diana²,Lee Kathy⁴,Knowles Sandra¹³,Mamdani Muhammad M.¹³⁵⁶⁷,Juurlink David N.²⁷⁸⁹,Gomes Tara¹²³⁸

Affiliation:

1. Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada

2. The Institute for Clinical Evaluative Sciences, Toronto, ON, Canada

3. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

4. Canadian Institute for Health Information, Ottawa, ON, Canada

5. The Sunnybrook Research Institute, Toronto, ON, Canada

6. Department of Medicine, St. Michael’s Hospital, Toronto, ON, Canada

7. Department of Medicine, University of Toronto, Toronto, ON, Canada

8. Departments of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada

9. Departments of Pediatrics, University of Toronto, Toronto, ON, Canada

Funder

Ontario Ministry of Health and Long-Term Care

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1586/14737167.2016.1167600

Reference33 articles.

1. Male hypogonadism

2. Dohle G, Arver S, Bettocchi C, et al. Guidelines on male hypogonadism: European Association of Urology. [cited 2012]. Available from: http://www uroweb org/gls/pdf/16_Male_Hypogonadism_LR%20II pdf, 2012.

3. A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians

4. FDA Drug Safety Communication: FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products. [cited 2014 Jan 31]. Available from: http://www fda gov/Drugs/DrugSafety/ucm383904 htm, 2014.

5. Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline